Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Studies on the Effects of Infusion of Enzyme Inhibitors on Mouse Adenosine Deaminase

PAUL P. TROTTA, MARY P. AHLAND, GEORGE F. BROWN and M. EARL BALIS
Molecular Pharmacology January 1978, 14 (1) 199-209;
PAUL P. TROTTA
Memorial-Sloan-Kettering Cancer Center, New York, New York 10021
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARY P. AHLAND
Memorial-Sloan-Kettering Cancer Center, New York, New York 10021
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGE F. BROWN
Memorial-Sloan-Kettering Cancer Center, New York, New York 10021
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. EARL BALIS
Memorial-Sloan-Kettering Cancer Center, New York, New York 10021
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Two inhibitors of adenosine deaminase, 9-erythro-(2-hydroxy-3-nonyl)adenine (EHNA) and 9-β-D-arabinofuranosyl-6-hydroxylaminopurine (ara-HA), which represent relatively tight and weak binding substrate analogues, respectively, were infused into mice over a period of 5 days. Nine different tissues were excised, and adenosine deaminase activity levels, as well as selected kinetic parameters and electrophoretic variants, were characterized. Isoelectric focusing demonstrated two variants (adenosine deaminases I and II) that focused in the pH range 4.65-4.75 and exhibited an approximate apparent molecular weight of 36,000 by gel filtration. The ratio of these two forms, which differed from tissue to tissue, was unaffected by the inhibitor infusions. Striking increases in adenosine deaminase activity were observed after the infusions and were found to vary with the tissue as well as the nature and dose of inhibitor. Activities in the lung, stomach, liver, and jejunum increased by about 8-, 3-, 3-, and 2-fold, respectively, after infusion of no more than 0.6 mg/ml of EHNA. Other tissues displayed significant but smaller increases. The effects of ara-HA were generally smaller than those of EHNA, except in the jejunum, ileum, and thymus. Inhibition of adenosine deaminase in vitro by EHNA, and to a lesser extent by ara-HA, also varied from tissue to tissue, but did not correlate with the ratio of adenosine deaminases I and II. Adenosine deaminase partially purified from mice treated with a higher dose of EHNA (5.0-7.5 mg/ml) displayed a significantly lower Ki value for EHNA; smaller decreases were noted in the Km, for adenosine. The most striking change was observed in the Km of adenosine deaminase II for EHNA, which changed from 14.9 nM (control) to 3.1 nM (after infusion). By classical Ackermann-Potter plots EHNA was shown not to be a titrating or stoichiometric inhibitor either before or after the infusions. EHNA in all cases showed classical competition with substrate. The data may be of value in the development of combined chemotherapy regimens involving adenosine deaminase inhibitors as well as in understanding the molecular basis of the role of adenosine deaminase in regulating cell division.

  • Copyright © 1978 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 14, Issue 1
1 Jan 1978
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Studies on the Effects of Infusion of Enzyme Inhibitors on Mouse Adenosine Deaminase
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Studies on the Effects of Infusion of Enzyme Inhibitors on Mouse Adenosine Deaminase

PAUL P. TROTTA, MARY P. AHLAND, GEORGE F. BROWN and M. EARL BALIS
Molecular Pharmacology January 1, 1978, 14 (1) 199-209;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Studies on the Effects of Infusion of Enzyme Inhibitors on Mouse Adenosine Deaminase

PAUL P. TROTTA, MARY P. AHLAND, GEORGE F. BROWN and M. EARL BALIS
Molecular Pharmacology January 1, 1978, 14 (1) 199-209;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Michaelis Menten quantification of GPCR-G protein signalling
  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics